(Best Syndication News) Panic attacks can come on suddenly and peak usually within ten minutes – but can last even longer. The Mayo Clinic reports that these attacks could be triggered by something that is not dangerous but can be frightening and cause the sufferer to think they are losing control or even having a heart attack.

Most people may suffer two panic attacks in their lifetime, but frequent attacks can affect the quality of life. Small stressful situations could cause recurrent and unexpected attacks.

The panic attacks can release a sudden wave of adrenalin. This can increase heart rate.

(Best Syndication News) - The U.S. Food and Drug Administration (FDA) approved Juxtapid (lomitapide) to treat a rare homozygous familial hypercholesterolemia (HoFH) disorder. Juxtapid should lower the low-density lipoprotein (LDL) cholesterol levels, the total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol. The drug should be prescribed in conjunction with a low fat diet and other lipid reduction treatments.

In the United States, around one in one million people have HoFH. People with the rare condition do not effectively remove “bad” LDL cholesterol from their body. This puts HoFH individuals at an increased risk for heart attacks and death, often before the age of 30.

(Best Syndication News) - Women who had deficient levels of vitamin D early on during their pregnancy were at an increased risk for having a baby with a lower birth weight. The study results will be reported in the January print edition and online in the Journal of Clinical Endocrinology & Metabolism.

The study was funded by the National Institutes of Health and was conducted by researchers from the University of Pittsburg Graduate School Of Public Health. Lead author, Alison Gernand, Ph.D., M.P.H., R.D., post-doctoral associate in Pitt Public Health's Department of Epidemiology, explained that being deficient in vitamin D during the first trimester put the fetus at twice the risk of restricted growth during the pregnancy.

(Best Syndication News) - The U.S. Food and Drug Administration announced that Matrixx Initiatives is recalling one lot of Zicam Extreme Congestion Relief nasal gel. The company announced the recall after a single sample tested positive for Burkholderia cepacia during a routine check at their manufacturing location. Now other samples tested positive, however, out of extreme caution, a recall has been announced.

There is very little medical risk for Burkholderia cepacia. There is a potential to infect individuals that have a weakened immune system or a chronic lung condition. An infection of Burkholderia cepacia can be difficult to get rid of with antibiotics because it is resistant.

(Best Syndication News) - Researchers found that overweight type-2 diabetes patients increased their chances of partial and complete remission with intensive lifestyle intervention. The results, which showed modest remission rates, were reported in the December 19, 2012 issue of JAMA.

Many people diagnosed with type-2 diabetes wonder if the disease is reversible. Diabetes is thought of as a disease that is progressive that will eventually lead to vascular and neuropathic damage. Other studies involving bariatric surgery on type 2 diabetes patients suggested that some cases could be resolved. There were no studies on the rate of remission with lifestyle modifications alone. This prompted Edward W. Gregg, Ph.D., of the Centers for Disease Control and Prevention, Atlanta, and his colleagues to investigate.